Status: current, Primitive. Date: 29-Feb 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1520171000168110 | Laila-35 ED (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1520181000168113 | Laila-35 ED | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Laila-35 ED | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Laila-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28, blister pack | has TP | True | Laila-35 ED | Inferred relationship | Some | |
| Laila-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | has TP | True | Laila-35 ED | Inferred relationship | Some | |
| Laila-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet | Is a | True | Laila-35 ED | Inferred relationship | Some | |
| Laila-35 ED (inert substance) tablet | Is a | True | Laila-35 ED | Inferred relationship | Some | |
| Laila-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has TP | True | Laila-35 ED | Inferred relationship | Some | |
| Laila-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28, blister packs | has TP | True | Laila-35 ED | Inferred relationship | Some |
Reference Sets
FHIR